IDERJ - Instituto de Dermatologia e Estética do Brasil- Site Number : 0760004

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Atopic dermatitis (eczema)

Running trials

• Active, not recruiting

  Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT05769777· Phase 2· Sanofi· Source